Postdoctoral Fellow, Multiple Myeloma Immuno-Oncology, Oncology Bioscience

AstraZeneca plc

Cambridge

On-site

GBP 76,000 - 91,000

Full time

14 days+

A complete application in a minute

Tailored resume and cover letter, ready to send.

Get past ATS filters

Job summary

AstraZeneca is seeking a highly motivated postdoctoral fellow to join the Oncology Bioscience group in Cambridge, MA. The role centers on mechanistically novel induction of tumor regression via innate immune engagement in multiple myeloma models.

You will lead in vivo studies, define innate immune cell contributions, and explore combination strategies with T-cell therapies, contributing to a strong publication roadmap.

Qualifications

  • PhD in Immunology, Hematology, Cancer Biology, Molecular or Cell Biology.
  • Strong publication record with at least one first-author/co-first-author paper.
  • Hands-on experience with in vivo mouse models including tumor implantation and treatment studies.
  • Proficiency in core molecular and cellular biology techniques.
  • Background in hematological malignancies, especially multiple myeloma, required.

Responsibilities

  • Lead in vivo studies in mouse models to characterize non-cancer cell autonomous function of a kinase inhibitor.
  • Dissect mechanistic contributions of innate immune cell types using CRISPR models and immune depletion/reconstitution.
  • Apply immunophenotyping and transcriptomic platforms (CyTOF, scRNA-seq, CITE-seq) to define pathways.
  • Evaluate rational combinations with T-cell engagers and CAR-T therapies.
  • Develop a publication plan including first-author papers within the term.

Skills

In vivo models
CRISPR editing
Flow cytometry
Western blot
ELISA
RNA-seq
CyTOF
CITE-seq

Education

PhD in Immunology/Hematology/Cancer Biology

Tools

CRISPR
Flow cytometry
Western blot
ELISA
RNA-seq
CyTOF
CITE-seq

Job description

Postdoctoral Fellow, Multiple Myeloma Immuno-Oncology, Oncology Bioscience

Location: Cambridge, MA

AstraZeneca is seeking a highly motivated and scientifically rigorous postdoctoral fellow to join the Oncology Bioscience group in Cambridge. This position sits at the intersection of cancer biology and innate immunology, centered on a mechanistically novel discovery: that inhibition of a first-in-class kinase target can regulate tumor growth both through direct cell autonomous oncogenic signaling and non-cancer cell autonomous modulation of the innate immune system.

This work is built around a potent and selective first-in-class AstraZeneca compound, grounded in compelling preliminary in vivo data demonstrating that target inhibition drives tumor regression through innate immune engagement in multiple myeloma models. The postdoc will characterize this mechanism, identify the specific innate immune cell types responsible, and evaluate rational combination strategies with T-cell directed therapies.

This is a rare opportunity to lead a mechanistically novel program with direct translational relevance, publish in high-impact journals, and work alongside experts in oncology.

This postdoc role will report to Kayleigh Gallagher (Associate Principal Scientist) and be supported by Omid Tavana (Senior Director) at AstraZeneca.

Major Responsibilities
  • Lead in vivo studies in syngeneic and xenograft mouse models to establish and characterize the non-cancer cell autonomous function of a first-in-class kinase inhibitor in multiple myeloma
  • Dissect the mechanistic contribution of individual innate immune cell types through CRISPR-based models, immune cell depletion, and reconstitution experiments
  • Apply advanced immunophenotyping and transcriptomic platforms, including CyTOF, single-cell RNA-seq, and CITE-seq, to define pathway modulation across innate immune compartments
  • Evaluate rational combination strategies with T-cell engagers and CAR-T therapies in relevant preclinical models
  • Drive a clear publication plan, including a first-author review in Year1 and a first-author research manuscripts over the three-year term
Minimum Requirements
  • Candidates must be within four years of receiving their doctoral degree (PhD, DVM or MD), with the PhD already awarded; or
  • Candidates who are nearing completion of their doctoral degree are eligible, provided the PhD is conferred within six months of joining AstraZeneca.
  • Education: Ph.D. in Immunology, Hematology, Cancer Biology, Molecular or Cell Biology, or a related field.
  • Training in a research-intensive academic laboratory with a strong publication record, including at least one first-author or co-first-author publication in a high-impact peer-reviewed journal
  • Hands-on experience with in vivo mouse models, including tumor implantation and treatment studies
  • Proficiency in core molecular and cellular biology techniques: flow cytometry, CRISPR cell line generation, western blot, ELISA, and cell-based functional assays
  • Background in hematological malignancies, particularly multiple myeloma
  • Strong scientific communication skills, with demonstrated ability to interpret and present complex datasets
Preferred Qualifications
  • Experience with xenograft mouse models (SCID, NSG) and immune cell depletion or reconstitution approaches
  • Familiarity with innate immune biology, including NK cell and macrophage biology
  • Exposure to advanced transcriptomic methods, including single-cell RNA-seq, CyTOF, or CITE-seq
Compensation for this role

Compensation for this role, based on years of experience after obtaining PhD, is a minimum of $99,900 up to a maximum of $120,000 + short-term incentive. Some relocation supplements depend on distance and location at the employer's discretion.

Why This Role

The postdoc will be embedded in a highly collaborative, multidisciplinary environment with direct access to internal experts in innate immunology, in vivo oncology, and clinical-stage hematology drug discovery. External mentorship will be provided by a leading investigator in the multiple myeloma field, offering additional scientific guidance and career development support. The program is supported by a fully resourced in vivo infrastructure, established assay platforms, and a clear publication roadmap.

About AstraZeneca

AstraZeneca is a global, science-led, patient-centered biopharmaceutical company focusing on discovering, developing, and commercializing prescription medicines for some of the world's most serious diseases. But we're more than a global leading pharmaceutical company. At AstraZeneca, we're dedicated to being a Great Place to Work and empowering employees to push the boundaries of science and fuel their entrepreneurial spirit.

AstraZeneca R&D Boston is a vibrant scientific community. The diverse make-up of our scientific teams, as well as our co-location with biotechs, results in a truly outstanding culture bursting with scientific innovation.

Where can I find out more? AZ's Postdoc Program: https://careers.astrazeneca

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

Postdoc - Myeloma Immuno-Oncology & First-in-Class Kinase
Postdoc - Myeloma Immuno-Oncology & First-in-Class Kinase

AstraZeneca plc • Cambridge

On-site
GBP 76,000 - 91,000
Senior Director, Competitive Intelligence, Oncology R&D
Senior Director, Competitive Intelligence, Oncology R&D

AstraZeneca plc • Cambourne

On-site
GBP 165,000 - 248,000
Senior Global Development Scientist, Director
Senior Global Development Scientist, Director

AstraZeneca plc • Cambourne

On-site
GBP 177,000 - 265,000
Senior Director, Frontier Science - Early Infectious Disease
Senior Director, Frontier Science - Early Infectious Disease

AstraZeneca plc • Cambridge

On-site
GBP 140,000 - 210,000
Senior Ai Impact & Applied Innovation Specialist
Senior Ai Impact & Applied Innovation Specialist

AstraZeneca plc • Cambourne

On-site
GBP 90,000 - 120,000
Excellent Benefits
Associate Principal Scientist – Upstream Process Development (Temporary Maternity Cover)
Associate Principal Scientist – Upstream Process Development (Temporary Maternity Cover)

AstraZeneca plc • Cambridge

On-site
GBP 70,000 - 100,000
Head Of Alliance And Integration Management Oncology
Head Of Alliance And Integration Management Oncology

AstraZeneca plc • Cambourne

Hybrid
GBP 204,000 - 307,000
Incentives
Equity awards
Retirement programs
+1
Principal Scientist, Discovery Biosciences Genomics, Oncology Trc
Principal Scientist, Discovery Biosciences Genomics, Oncology Trc

Bristol Myers Squibb • Cambourne

On-site
GBP 118,000 - 143,000
Comprehensive benefits
Flexible work options
Cell Therapy Non-Clinical Safety Director
Cell Therapy Non-Clinical Safety Director

Astrazeneca • Cambridge

Hybrid
GBP 90,000 - 130,000
Executive Director Clinical Operations, Program Management
Executive Director Clinical Operations, Program Management

AstraZeneca plc • Cambourne

Hybrid
GBP 231,000 - 347,000